
Anthropic's AI model, Claude, has successfully ventured into protein design, a crucial step in drug discovery. The model autonomously ran campaigns that resulted in molecules with a 22-35% success rate in targeting proteins, outperforming the industry norm of 10-15%. This achievement highlights the capability of general AI models to handle complex scientific tasks. Although Anthropic did not perform the lab work, partners such as Twist Bioscience confirmed the AI's results, showcasing a significant advancement in AI applications within biotechnology.
Read original